Journal of Oncology / 2014 / Article / Tab 3

Clinical Study

Survival Advantage Associated with Decrease in Stage at Detection from Stage IIIC to Stage IIIA Epithelial Ovarian Cancer

Table 3

Demographic data Stage IIIA versus Stage IIIC epithelial ovarian cancer, US SEER 18 Registries 2000–2009.

StageIIIAIIICSignificance

Number79411,967
Age at diagnosis (mean)


Race
 Black49 (6.2%)712 (5.9%)
 White680 (85.6%)10,456 (87.4%)
 Other65 (8.2%)799 (6.7%)
Appalachian Region
 Appalachia30 (3.8%)539 (4.5%)
 Non-Appalachia764 (96.2%)11,428 (95.5%)
Urban region
 Rural78 (9.8%)1,199 (10.0%)
 Urban716 (90.2%)10,768 (90.0%)
Cell type
 Serous carcinoma396 (50.0%)7,952 (66.4%)
 Endometrioid carcinoma90 (11.3%)740 (6.2%)
 Mixed adenocarcinoma (NOS)32 (4.0%)437 (3.7%)
 Mucinous carcinoma91 (11.5%)1,282 (10.7%)
 Carcinoma (NOS), other185 (23.2%)1,556 (13.0%)

NOS: not otherwise specified.